Biomarin Pharmaceutical

Price & Volume

Track all markets on TradingView

Stats

See more
52W Range
$56.85-$94.85
Market Cap
$11.4B
Shares Short
4M

Financials

See more
Revenue (12 Mos)
$2.8B
Revenue Growth (YoY)
15.6%
Gross Profit (12 Mos)
$2.2B
Diluted EPS
$2.21

News

See more

Yahoo Finance • 20 days ago

BioMarin Presents New Data Demonstrating Favorable Safety and Strong Adherence in Real-World Clinical Practice with VOXZOGO® (vosoritide) in Children Under 3 with Achondroplasia at 2025 American College of Medical Genetics and Genomics (ACMG) Annual Clinical Genetics Meeting

Yahoo Finance • 2 months ago

BioMarin Pharmaceutical Full Year 2024 Earnings: Beats Expectations

Yahoo Finance • 2 months ago

Is BioMarin Pharmaceutical (BMRN) the Best Depressed Stock to Invest in Now?

Yahoo Finance • 8 months ago

U.S. Food and Drug Administration Approves BioMarin's BRINEURA® (cerliponase alfa) for Children Under 3 Years with CLN2 Disease

About

CEO
Mr. Alexander Hardy
CFO
Mr. Brian R. Mueller CPA
Address
770 Lindaro Street, San Rafael, CA, United States, 94901
Sector
Healthcare
Industry
Biotechnology
Full-Time Employees
3,040